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Prospective and Retrospective Memory Complaints in Mild
Cognitive Impairment and Mild Alzheimer's Disease
Abstract
Current management attempts for Alzheimer's disease (AD) focus on the identification of individuals in
the preclinical stage. This has led to the development of the diagnostic concept of Mild Cognitive
Impairment (MCI), which applies to individuals with declining cognitive abilities but largely preserved
everyday functioning. Previous findings indicate that prospective memory deficits are a sensitive marker
of preclinical AD and that awareness of prospective memory failures is particularly high, based on its
dependence on executive functions. Thus, the goal of this study was to evaluate the usefulness of
subjective prospective versus retrospective memory complaints for an initial screening for MCI and
their respective associations with executive functions. 71 healthy older adults, 27 MCI patients, and 9
patients with mild AD completed the Prospective and Retrospective Memory Questionnaire (PRMQ)
and three executive functions tests. The healthy and the MCI group could not be distinguished by their
level of subjective prospective or retrospective memory complaints, but the mild AD patients differed
from the other groups by complaining more about retrospective than prospective memory failures. For
the healthy older adults, the prospective memory complaints were correlated to an inhibition test,
whereas they did not correlate with any of the executive function tests in the MCI patients. In contrast,
in both groups the retrospective memory complaints were related to a task switching test. The findings
are discussed with respect to differences between the three groups in cognitive abilities, attention to
failures of, use of mnemonic aids for, and everyday demands of prospective and retrospective memory.
                                                                                  Prospective and Retrospective 1
 
Running Head: PROSPECTIVE AND RETROSPECTIVE MEMORY COMPLAINTS 
 
 
 
Prospective and Retrospective Memory Complaints in Mild Cognitive Impairment and 
Mild Alzheimer’s Disease 
 
 
Anne Eschen1 
Mike Martin2 
Ursula Schreiter Gasser3 
Matthias Kliegel4 
 
 
 
Correspondence concerning this article should be addressed to Anne Eschen, Institute 
of Psychology, University of Zurich, Binzmuehlestr. 14/24, CH-8050 Zürich 
Switzerland. Electronic mail may be sent to a.eschen@psychologie.uzh.ch . 
 
 
 
 
                                                 
1
 Ph. D., Institute of Psychology, University of Zurich, Binzmuehlestr. 14 / 24, 8050 Zurich, Switzerland  
2
 Prof., Institute of Psychology, University of Zurich, Binzmuehlestr. 14 / 24, 8050 Zurich Switzerland 
3
 Adj. Prof., Gerontopsychiatric Centre, Psychiatric University Hospital Zurich, now at Praxis for 
Psychiatry Rehalp, Forchstrasse 364, 8008 Zurich, Switzerland 
4
 Prof., Department of Psychology, Technische Universität Dresden, 01062 Dresden, Germany 
                                                                                  Prospective and Retrospective 2
Abstract 
Current management attempts for Alzheimer’s Disease (AD) focus on the identification 
of individuals in the preclinical stage. This has led to the development of the diagnostic 
concept of Mild Cognitive Impairment (MCI) which applies to individuals with 
declining cognitive abilities but largely preserved everyday functioning. Previous 
findings indicate that prospective memory deficits are a sensitive marker of preclinical 
AD and that awareness of prospective memory failures is particularly high, based on its 
dependence on executive functions. Thus, the goal of this study was to evaluate the 
usefulness of subjective prospective versus retrospective memory complaints for an 
initial screening for MCI and their respective associations with executive functions. 71 
healthy older adults, 27 MCI patients, and 9 patients with mild AD completed the 
Prospective and Retrospective Memory Questionnaire (PRMQ) and three executive 
functions tests. The healthy and the MCI group could not be distinguished by their level 
of subjective prospective or retrospective memory complaints, but the mild AD patients 
differed from the other groups by complaining more about retrospective than 
prospective memory failures. For the healthy older adults, the prospective memory 
complaints were correlated to an inhibition test, whereas they did not correlate with any 
of the executive function tests in the MCI patients. In contrast, in both groups the 
retrospective memory complaints were related to a task switching test. The findings are 
discussed with respect to differences between the three groups in cognitive abilities, 
attention to failures of, use of mnemonic aids for, and everyday demands of prospective 
and retrospective memory.  
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Prospective and Retrospective Memory Complaints in Mild Cognitive Impairment and 
Alzheimer’s Disease 
With growing life expectancy, Alzheimer’s Disease (AD) has become a major 
health challenge for industrialized countries (Sloane et al., 2002). Clinical diagnosis of 
AD requires the presence of multiple cognitive deficits and impairment of everyday 
functioning (see fourth edition of the Diagnostic and Statistical Manual for Mental 
Disorders, DSM-IV; American Psychiatric Association, 1994). This has been 
considered as a very late stage for possible therapeutic intervention in the 
neuropathological process (Reisberg & Gauthier, 2008) and, therefore, current 
management attempts focus on the identification of individuals in the transitional state 
between normal aging and AD characterized by first cognitive impairments, but still 
largely preserved functional abilities (Caselli, Beach, Yaari, & Reiman, 2006; Leifer, 
2003). 
Among diagnostic concepts developed for this purpose (see Reisberg et al., 
2008 for an overview), Mild Cognitive Impairment (MCI) as proposed by the 
International Working Group on Mild Cognitive Impairment (Winblad et al., 2004) has 
lately achieved the most general acceptance. However, it has been criticized for its 
heterogeneity (Rockwood, Chertkow, & Feldman, 2007): although there is a markedly 
higher incidence of AD in individuals with MCI as compared to the general population 
(Petersen & Negash, 2008), a rather high percentage develops other dementias, remains 
stable, or even reverts to a cognitively intact status (Ganguli, 2006). Furthermore, 
prevalence of MCI and conversion rates to AD vary between different studies, caused 
by differences in populations being studied (clinic attenders or normal population) and 
in specific operationalization of MCI criteria (Bruscoli & Lovestone, 2004; Panza et al., 
2005). 
                                                                                  Prospective and Retrospective 4
Diagnostic criteria for MCI are (a) the person is neither normal nor demented, 
(b) there is evidence of cognitive deterioration shown by either decline in 
neuropsychological test performance over time and/or subjective report of decline by 
self and/or informant in conjunction with objective cognitive deficits as defined by 
neuropsychological test performance below age-adjusted norms, and (c) activities of 
daily living are preserved and complex instrumental functions are either intact or 
minimally impaired. As for AD diagnosis, other causes for cognitive dysfunction have 
to be excluded. For first diagnostic assessment of MCI a stepwise procedure is 
recommended: first the examination of cognitive complaints by the person assessed or 
a close acquaintance of this person, then the assessment of the person’s cognitive and 
functional abilities. Since information from an acquaintance takes time and might be 
difficult to acquire, the question arises whether self-reported cognitive deficits 
constitute a useful initial screening for MCI. 
Such a screening should distinguish MCI patients from healthy older adults as 
well as from mild AD patients. Studies with elderly population-based samples (Fisk, 
Merry, & Rockwood, 2003; Fisk & Rockwood, 2005; Jungwirth et al., 2004; Luck, 
Busse, Hensel, Angermeyer, & Riedel-Heller, 2008; Purser, Fillenbaum, & Wallace, 
2006) question the ability of self-reported cognitive impairments to discriminate MCI 
patients from healthy older adults. They demonstrated that about as many people with 
cognitive impairments and largely preserved everyday functioning complained about 
cognitive impairments as not. Furthermore, many people with normal cognitive and 
functional abilities also complained about cognitive deficits.  
However, in these studies subjective cognitive complaints were assessed with a 
single question regarding memory impairment which seems to be inappropriate with 
regard to its specificity and sensitivity for MCI. Cognitive impairment indicative for 
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MCI is defined by neuropsychological test performance below age-adjusted norms. 
However, normal aging is associated with mild cognitive decline and thus many older 
adults will judge their memory as impaired. On the other hand, since MCI patients may 
experience deficits in other cognitive domains than memory and do not show 
impairments in most aspects of everyday functioning, many of them will judge their 
memory as intact. Therefore, a screening instrument for subjective cognitive 
complaints suggestive for MCI should rather include several questions regarding 
different aspects of cognitive functioning and differences between MCI patients and 
healthy older adults should arise in their level of positive answers or ratings. The same 
holds true for the differentiation between MCI and mild AD patients, because they also 
only differ in their level of cognitive and functional impairment. 
Indeed, several studies using questionnaires or interviews about everyday 
impairments in memory (Clément, Belleville, & Gauthier, 2008; De Jager & Budge, 
2005; Perrotin, Belleville, & Isingrini, 2007) or in several cognitive domains (Kliegel, 
Zimprich, & Eschen, 2005; Rabin et al., 2006) have demonstrated that MCI patients 
report a higher level of subjective cognitive complaints than healthy older adults, but a 
similar level of subjective memory (Clément et al., 2008) or general cognitive 
complaints (Kalbe et al., 2005) as mild AD patients. 
The latter findings have been explained with the diminished insight of the mild 
AD patients in their cognitive deficits. On cognitive questionnaires, they evaluate their 
cognitive abilities as more positive than their carers (e.g.,, Cahn-Weiner, Ready, & 
Malloy, 2003; Derousné et al., 1999). However, findings by Vogel, Hasselbach, Gade, 
Ziebell, and Waldemar (2005) also question insight of MCI patients: in comparison 
with their carers, MCI patients underreported their cognitive deficits to a similar degree 
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as mild AD patients. In contrast, Kalbe and colleagues (2005) found MCI patients to 
over- and mild AD patients to underreport their cognitive impairments. 
These differential findings might be caused by differences in the instruments 
used. Kalbe and colleagues questioned their participants on various cognitive abilities, 
while Vogel and colleagues used a memory questionnaire only, suggesting that MCI 
patients have a diminished insight for this cognitive ability specifically. This is 
surprising, since episodic memory impairment is one of the earliest and best cognitive 
predictors of AD (Almkvist, 1996; Bäckman, Jones, Berger, Laukka, & Small, 2005; 
Rubin et al., 1998) and the MCI patients in Vogel and colleagues’ study had a severe 
impairment in this cognitive domain only. Kalbe and colleagues, however, did not find 
significant differences between the MCI and AD patients’ and their caregivers’ ratings 
for their memory question. Clément and colleagues (2008) reported that although their 
MCI and mild AD patients had similar sum scores on a memory questionnaire, the AD 
patients had significantly higher scores than their healthy older sample on 3 of 10 
questionnaire subsections referring to different memory types, whereas the MCI 
patients had significantly higher scores than the healthy older adults on these and three 
additional subsections. This suggests that only questionnaires on certain types of 
memory impairments might be useful to discriminate between healthy older adults, 
MCI patients, and mild AD patients. 
Research on episodic memory impairment in AD has so far mainly concentrated 
on one of its domains, that is retrospective memory, whereas prospective memory has 
largely been neglected. While retrospective memory relates to remembering past 
events, prospective memory refers to remembering to carry out planned actions at pre-
specified times in the future (McDaniel & Einstein, 2007). Prospective memory has a 
retrospective component (remembering which actions were intended for what times), 
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but involves distinct processes (termed prospective component) that enable self-
initiated punctual action execution (for verification of discriminant validity of 
prospective versus retrospective memory see Salthouse, Berish, & Siedlecki, 2004 and 
Zeintl, Kliegel, & Hofer, 2007). Among these distinct processes, executive functions, 
such as monitoring for execution times while performing other activities, inhibition of 
ongoing activities, and initiation of the planned actions at the critical times, seem to 
play a leading role (for detailed task analyses see Burgess & Shallice, 1997; Ellis, 
1996; Knight, 1998; for evidence on greater involvement of executive functions versus 
retrospective memory see Kopp & Thöne-Otto, 2003; McDaniel, Glisky, Rubin, 
Guynn, & Routhieaux, 1999). 
To date, only a few studies have compared the sensitivity of prospective and 
retrospective memory as an early indicator of AD. Maylor, Smith, Della Sala, and 
Logie (2002) found that individuals with mild to moderate AD performed worse than 
healthy controls on prospective memory tasks, but were even more impaired on 
retrospective memory tasks. Surprisingly, the retrospective component of the 
prospective memory task was intact in all their AD patients. Duchek, Balota, and 
Cortese (2006) also demonstrated a clear prospective memory deficit relative to healthy 
controls in older adults with very mild AD. The authors did not directly compare 
prospective and retrospective memory performance of their participants, but 
demonstrated that the prospective memory performance helped to discriminate between 
the very mild AD patients and healthy adults above and beyond retrospective memory 
performance. Moreover, within their prospective memory task, the AD patients’ 
impairment was greater for the prospective than for the retrospective component. 
Finally, in a large longitudinal population-based study, Jones, Livner, and Bäckman 
(2006) found that compared to participants who remained healthy, participants who 
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three years later received an AD diagnosis showed similar deficits in prospective and 
retrospective memory. Additionally, their impairments in the retrospective and the 
prospective component of the prospective memory task were of equal size. In 
summary, these findings indicate that prospective memory is a similarly sensitive 
marker of preclinical or early AD as retrospective memory. 
With regard to subjective memory complaints, prospective memory complaints 
may have a higher discriminative power than retrospective memory complaints for 
MCI. Mäntylä (2003) suggested that people are more aware of their prospective than 
their retrospective memory failures because prospective memory tasks involve more 
executive and thus conscious, self-initiated behaviour and are, therefore, more often 
subject to conscious perception and evaluation processes. Furthermore, people may 
monitor their prospective memory performance more closely than their retrospective 
memory performance since prospective memory failures seem to cause a greater 
impairment in everyday functioning (Kliegel & Martin, 2003) and have more negative 
social consequences - they are attributed to a person’s lack of reliability, whereas 
retrospective memory failures are ascribed to a weakness of a person’s memory 
(Winograd, 1988). 
With the Prospective and Retrospective Memory Questionnaire (PRMQ; Smith, 
Della Sala, Logie, & Maylor, 2000), a questionnaire specifically developed for 
capturing differences between subjective prospective and retrospective memory 
complaints, a greater awareness for prospective than for retrospective memory failures 
has been consistently found in the normal population (Crawford, Smith, Maylor, Della 
Sala, & Logie, 2003; Kliegel & Jäger; 2006; Mäntylä, 2003; Rönnlund, Mäntylä, & 
Nilsson, 2008; Singer, Falchi, MacGregor, Clerkas, & Spector, 2006; Smith et al., 
2000). Furthermore, Singer and colleagues (2006) could demonstrate a specific 
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association of subjective prospective memory complaints with executive functions: in a 
large sample of healthy twins the PRMQ Prospective Scale was not correlated to 
classical retrospective memory tasks, but to a working memory task only. However, 
Smith and colleagues (2000) found the PRMQ Prospective and Retrospective Scales to 
discriminate AD patients from healthy older adults equally well. Nevertheless, Smith 
and colleagues had asked the carers of their AD patients to complete the PRMQ on the 
patients’ behalf and the objectivity of the carers’ judgement was questioned by the 
finding that the carers evaluated their own everyday prospective and retrospective 
memory better than age-matched healthy control participants. 
Therefore, the first aim of this study was to evaluate the usefulness of self-
reported prospective versus retrospective memory complaints as an initial screening for 
MCI by comparing the ratings of a group of healthy older adults, a group of MCI 
patients, and a group of mild AD patients on the Prospective and the Retrospective 
Scale of the PRMQ. It was anticipated that all participant groups complain more about 
prospective than retrospective memory failures. MCI patients were expected to report 
more prospective and retrospective memory failures than the healthy older adults, while 
the AD patients were expected to report more prospective memory failures than the 
MCI patients, but a similar amount of retrospective memory failures. 
The second aim of this study was to evaluate Mäntylä’s claim that greater 
awareness of everyday prospective than retrospective memory competence is based on 
its greater dependence on executive functioning and whether this applies to healthy 
older adults as well as to MCI patients for whom insight in their memory competence 
has been questioned. This was done by calculating correlations between the scores of 
the healthy older adults or MCI patients, respectively, on the PRMQ Prospective and 
Retrospective Scales and on three executive function tests. It was expected that for both 
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healthy older adults and MCI patients, at least one of the executive function tests would 
be correlated to the Prospective Scale, but none to the Retrospective Scale. 
Method 
Participants 
In total, 107 participants were included in the analyses: 27 MCI patients, 9 
patients with mild AD, and 71 healthy older controls. 
MCI and AD Patients.  
The MCI and AD patients were recruited out of 311 in- and outpatients of the 
Gerontopsychiatric Centre of the Psychiatric University Hospital Zurich who 
underwent a neuropsychological examination as part of an extensive diagnostic 
assessment for self- or informant-reported cognitive decline between July 2003 and 
June 2005 for the first time. At the end of the neuropsychological examination, patients 
who were not handicapped by too severe perception, language, or comprehension 
impairments were asked to complete the PRMQ. In total, 101 patients were able to and 
agreed to fill out the questionnaire. 
The neuropsychological test battery (see below) contained a depression 
screening questionnaire and tests for the cognitive domains memory, language, praxia, 
perception, executive functions, attention, speed, and crystallized intelligence. 
Cognitive impairment was operationalized by test performance of at least one standard 
deviation below age-adjusted norms, since MCI diagnosis based on this cut-off score 
has been found to have the highest predictive power for later development of dementia 
(Busse, Hensel, Gühne, Angermeyer, & Riedel-Heller, 2006). In addition to the 
neuropsychological examination, a clinical interview with the patient and a person who 
knew the patient well was conducted to determine the patient’s level of functional 
ability, to evaluate the presence of psychiatric disorders including substance abuse, and 
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to obtain a medical history. The medical history was corroborated by and 
complemented with relevant previous medical reports about the patient. Furthermore, a 
neurological, a neuroradiological (either computer tomography or magnetic resonance 
imaging), and a laboratory examination were conducted to screen for neurological and 
systemic diseases known to cause cerebral dysfunction. Based on the assessment 
results, patients were diagnostically classified by a consensus conference of the 
multidisciplinary clinic staff.  
Out of the 101 patients who completed the PRMQ, 9 received the diagnosis of a 
probable AD according to the DSM-IV (American Psychiatric Association, 1994) and 
the NINCDS-ADRA criteria (McKhann et al., 1984), and 27 received the diagnosis of 
MCI according to the general MCI criteria as proposed by the International Working 
Group on Mild Cognitive Impairment (Winblad et al., 2004). All AD patients were in 
the mild stage of the disease as indicated by MMSE scores greater than 17 and by their 
individual neuropsychological profiles, that is their cognitive impairments were 
restricted to memory, naming, executive functions, and constructional praxia deficits 
(Ballard et al., 1999; Storey, Slavin & Kinsella, 2002). Like AD, MCI was only 
diagnosed when there was no evidence for neurological and systemic diseases, 
psychiatric disorders, or substance abuse that could account for the cognitive deficits. 
The remaining 65 patients who completed the PRMQ were excluded from the analyses 
for the following reasons: 1 did not complete the whole assessment procedure, 3 
showed normal test performance, 1 had a schizoaffective disorder, 16 for indication of 
a depressive episode (either by clinical diagnosis or by the scores on the depression 
screening questionnaire), 10 for alcohol abuse, 3 for epilepsy, 1 for a traumatic brain 
injury, 1 for a subdural hematoma, 12 for strokes or cerebrovascular haemorrhages, 2 
suffered from a subcortical vascular dementia, 11 from a mixed dementia, and 4 from 
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Parkinson’s Disease. Figure 1 shows a schematic overview of the diagnostic procedure 
for the MCI and the mild AD patients. 
------------------------------- 
Insert Figure 1 about here 
------------------------------- 
Healthy Older Controls.  
Altogether 80 community dwelling older adults aged between 54 and 91 years 
(in order to match for the typical patient age range of the Gerontopsychiatric Centre) 
were recruited as controls. They were screened with the help of a specifically designed 
health questionnaire and a depression screening questionnaire (see below) for the same 
exclusion criteria that were applied for the diagnosis of the MCI and AD patients: 
regular use of neurotoxic substances or neurological, psychiatric, and systemic diseases 
known to cause cognitive dysfunction. With this procedure, nine participants were 
excluded: five for indication of alcohol abuse and four for indication of a depressive 
episode (either by relevant information from the health questionnaire or by the scores 
on the depression screening questionnaire). 
Materials 
Depression Screening Questionnaires. 
For the patients the short form of the Geriatric Depression Scale (GDS; Sheikh 
& Yesavage, 1986) was used to screen for the presence of a depressive episode, 
whereas for the healthy elderly volunteers the depression subscale of the Hospital 
Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) was applied. Both 
questionnaires focus on emotional and motivational depressive symptoms, thus 
avoiding overlap with somatic symptoms common in aging. The GDS was chosen for 
the mostly cognitively impaired patients because of its easy response format (yes/no-
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format). For the healthy older adults, the HADS depression subscale was chosen 
because it has a greater score range and allows for graded responses to single items and 
therefore was expected to lead to a more accurate identification of depressive cases. 
Short form of the Geriatric Depression Scale (GDS). It includes 15 questions 
that can be agreed or disagreed to. Answers indicative of a depressive episode are 
summed up. Possible minimum and maximum scores are 0 and 15. Sum scores greater 
than 5 are considered to be suggestive, scores greater than 10 to be indicative of the 
presence of a depressive episode. GDS scores greater than 5 lead to exclusion from this 
study. All patients completed the GDS in the presence of their neuropsychologist and 
were thus able to ask comprehension questions. 
The depression subscale of the Hospital Anxiety and Depression Scale (HADS). 
It contains seven items (e.g.,, “I have lost interest in my appearance”). Participants have 
to indicate on a four-point rating scale (nearly all of the time, very often, sometimes, not 
at all) how often these symptoms occurred in the last week. These ratings are assigned 
numerical values of 3 (nearly all of the time) to 0 (not at all) and summed up. 
Consequently, possible scores range from 0 to 21. Scores between 8 and 10 are 
regarded as suggestive, scores of 11 and higher as indicative of the presence of a 
depressive episode. In this study, scores greater than 7 lead to exclusion. All healthy 
volunteers completed the HADS depression subscale in the presence of the 
experimenter and were thus able to ask comprehension questions. 
Neuropsychological Tests. 
MCI and AD patients. The neuropsychological examination for the MCI and 
AD patients included the German version of the Consortium to Establish a Registry for 
Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-NAB) that was 
scaled on a large Swiss German sample of healthy adults aged between 53 and 92 years 
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to provide age-, gender-, and education-specific norms (Berres, Monsch, Bernasconi, 
Thalmann, & Stähelin, 2000). It has been proven to discriminate between healthy older 
adults, patients with a major depression, with MCI, with mild, and with moderate AD, 
respectively (Barth, Schönknecht, Pantel, & Schröder, 2005) as well as between 
patients with mild AD, mild frontotemporal dementia, and mild semantic dementia 
(Diehl et al., 2005). The CERAD-NAB contains seven subtests: the Mini-Mental State 
Examination (MMSE; Folstein, Folstein, & McHugh, 1975), a semantic fluency test, a 
15-item form of the Boston Naming Test, a constructional praxia test, a visual delayed 
free recall test, a word list learning test, a delayed free recall, and a delayed recognition 
test for this word list. 
All participants. The following tests were completed by all participant groups. 
They were selected from the neuropsychological test battery for the MCI and AD 
patients, to allow for a short measurement of crystallized intelligence and executive 
functioning (i.e., working memory, task switching, and inhibition) in the healthy older 
adults. 
Crystallized intelligence was evaluated with the Mehrfachwahlwortschatztest B 
(MWT-B; Lehrl, 1977), a multiple-choice vocabulary test. Raw scores can be 
converted to IQ scores. Since crystallized intelligence is thought to be a product of both 
formal and informal educational efforts throughout life (see Cattell, 1987), this test was 
used as a second measure for educational attainment next to years of schooling which 
reflect by definition only formal educational efforts in the youth. 
Working memory was tested with the Digit Span backward subtest of the 
German version of the Wechsler Memory Scale-Revised (WMS-R; Härting et al., 
2000). Possible minimum and maximum scores are 0 and 12. 
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Task switching was measured with the Trail Making Test (TMT; Reitan, 1955; 
version and norms according to the new extended German CERAD-NAB online 
version “CERAD-Plus online”, Memory Clinic Basel). In Part A of the TMT (TMT-A), 
the time (in s) was measured that the participants needed to connect randomly 
distributed digits (1 - 25) in ascending order. This is regarded as a measure for motor 
speed. In Part B of the TMT (TMT-B) the time (in s) was measured that the participants 
needed to alternately connect randomly distributed digits (1 - 13) and letters (A - L) in 
ascending or alphabetical order, respectively. In the “CERAD-Plus online”-TMT 
version the quotient of time for Part B and time for Part A (TMT B/A) is used as a 
measure for task switching, thus controlling for motor speed. 
Inhibition was measured with the third plate of the Stroop-Victoria Test 
(Regard, 1981). The third plate depicts the words “yellow”, “red”, “blue”, and “green” 
(altogether 20) in the yellow, red, blue, and green with the colour of the words not 
corresponding to their meaning. The time (in s) was measured that the participants need 
to correctly state the colour of all words. 
Prospective and Retrospective Memory Complaints. 
For the assessment of the amount of prospective and retrospective memory 
complaints, all participants completed the German version of the Prospective and 
Retrospective Memory Questionnaire (PRMQ; Kaschel, 2002; original version by 
Smith et al., 2000). The PRMQ contains 16 items. Eight of these items refer to 
everyday prospective memory failures (e.g., “Do you fail to mention or give something 
to a visitor that you were asked to pass on?”) and form the Prospective Scale. The 8 
other items refer to everyday retrospective memory failures (e.g.,, “Do you fail to 
recognise a place you have visited before?”) and form the Retrospective Scale. The 
questions on both scales are matched for two other dimensions of episodic memory 
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(i.e., self- versus environmentally-cued retrieval and length of retention interval). On 
each item, one can indicate on a 5-point Likert-type rating scale (very often, quite often, 
sometimes, rarely, and never) how often one has recently experienced this particular 
memory failure. These ratings are assigned numerical values of 5 (very often) to 1 
(never) and are summed up. Consequently, possible minimum and maximum scores on 
the Prospective and Retrospective Scales are 8 and 40.  
Confirmatory factor analyses on the PRMQ items in a large British (Crawford, 
Smith, Maylor, Della Sala, & Logie, 2003) and in a large Swedish (Rönnlund, Mäntylä, 
& Nilsson, 2008) population-based sample have indeed proven a three-factor structure 
of the PRMQ with the Prospective and Retrospective Scale as orthogonal factors and 
episodic memory as a common factor. These studies also confirmed a high reliability of 
both scales (Crawford et al.: Cronbach’s alphas were 0.84 and 0.80; Rönnlund et al.: 
Cronbach’s alphas were 0.86. and 0.78 for the Prospective and Retrospective Scales, 
respectively). Additionally, concurrent validity of the Prospective Scale has been 
demonstrated: in healthy middle-aged (Mäntylä, 2003) and older adults (Kliegel & 
Jäger, 2006; Zeintl, Kliegel, Rast, & Zimprich, 2006), performance on laboratory 
prospective memory tasks was correlated to the PRMQ Prospective Scale. Moreover, 
Mäntylä (2003) could provide evidence that the Prospective Scale is indeed related to 
everyday prospective memory performance. He demonstrated that middle-aged women 
who specifically regarded their prospective memory as poor had higher scores than 
middle-aged women who considered their memory generally as intact only on the 
Prospective Scale. Additionally, the complaining women performed equally well as the 
non-complaining women on classical retrospective memory tasks, but were slightly 
impaired on laboratory and severely impaired on naturalistic prospective memory tasks.  
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All MCI and AD patients completed the PRMQ in the presence of their 
neuropsychologist; all healthy older adults in the presence of the experimenter. All 
participants were thus able to ask comprehension questions. 
Results 
Excluded Participants 
Excluded patients. 
There were no differences between excluded patients (n = 65) and the included 
MCI and mild AD patients (n = 36) in age (t(99) = -0.34, p < .80), years of schooling 
(U(65) = 412.5, p < .20), crystallized intelligence (U(84) = 814.0, p < .80), MMSE 
scores (U(100) = 981.5, p < .30), PRMQ Prospective (t(98) = 1.30, p < .30), and 
Retrospective Scale scores, t(96) = 0.20, p < .90. There was a significantly lower 
proportion of women (53.8% vs. 75.0%; χ2(1, N = 101) = 4.37, p = .036) and a trend 
towards a lower proportion of outpatients (69.2% vs. 86.1%; χ2(1, N = 101) = 3.54, p = 
.060) in the excluded patient group. They had significantly higher Geriatric Depression 
Scale scores than the included patients (Mdn = 6.0, range = 15 vs. Mdn = 2.0, range = 
5), U(99) = 373.0, p < .001. 
Excluded healthy controls.  
There were no differences between excluded (n = 9) and included healthy 
control participants (n = 71) in age (t(78) = -0.79, p < .50), gender (χ2(1, N = 80) = 
2.16, p = .141); crystallized intelligence (t(78) = -0.58, p < .60), PRMQ Prospective 
(t(78) = -0.90, p < .40), and Retrospective Scale scores, t(77) = -0.74, p < .50. The 
excluded healthy participants had more years of schooling (M = 15.00, SD = 2.50 vs. M 
= 13.30, SD = 2.86) and higher HADS depression subscale scores than the included 
healthy controls (M = 5.22, SD = 3.11 vs. M = 3.08, SD = 1.75), but these differences 
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just failed to reach significance level (t(8.65) = 2.02, p = .075; or t(78) = 1.71, p = .091, 
respectively). 
Participant Groups Characteristics 
Table 1 provides demographic data (age, gender, years of schooling, crystallized 
intelligence) about the three participant groups. For the MCI patients and the mild AD 
patients additionally GDS scores, proportion of outpatients, MMSE scores, and 
CERAD-NAB memory subtest scores are presented. 
------------------------------- 
Insert Table 1 about here 
------------------------------- 
Demographic variables.  
The three participant groups did not differ in age (F(2, 104) = 0.36; p < .80), or 
gender, χ2(2, N = 107) = 3.63, p < .20. There was a group difference with respect to 
formal education (F(1,104) = 3.28; p = .042), with post-hoc comparisons (Tukey a) 
indicating a trend to fewer years of schooling in the AD patients as compared to the 
healthy older adults, HSD = -2.18, p = .087. A Kruskal-Wallis test with participant 
group as between-subject variable was used to evaluate group differences in 
crystallized intelligence because variance homogeneity between groups was not given. 
According to this analysis (χ2(2, N = 105) = 28.98, p < .001), the groups differed in 
their crystallized intelligence level. Post-hoc comparisons (independent t tests) 
indicated that the healthy older adults had a higher crystallized intelligence level than 
the MCI (t(94) = 4.95, p < .001) and the AD patients, t(32.85) = 8.74, p < .001. The 
median crystallized intelligence level of the healthy older adults was above average and 
that of the MCI and the AD patients approximately average, with all participants 
individually having at least an average IQ (minimum IQ of the whole sample was 86). 
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This is in line with findings of higher incidence rates for MCI (Kumar et al., 2006; 
Panza et al., 2005; Tervo et al., 2004) and AD (see Caamaño-Isorna, Corral, Montes-
Martínez & Takkouche, 2006 for a meta-analysis) in older adults with lower 
educational attainment. 
Depressivity. 
Due to the strict selection procedure (exclusion of healthy older adults with 
scores greater than 7 on the HADS depression subscale and of patients with scores 
greater than 5 on the GDS), the reported level of depressivity in all participant groups 
was very low (for patient groups see Table 1; healthy participants: mean HADS 
depression subscale score = 3.08, SD = 1.75). The MCI and AD patients did not differ 
in GDS scores, t(34) = -.35, p < .80. 
Patient status of MCI and AD patients. 
The two patient groups did not differ in the relative proportion of in- and 
outpatients, χ2(1, N = 36) = 0.68, p < .50. The large majority of the patients were 
outpatients, indicating that most patients’ functional status was relatively mildly 
impaired. 
General cognitive status of MCI and AD patients. 
The MMSE scores of both patient groups were in the range regarded as typical 
for MCI and mild AD patients, that is for the MCI group between 24 and 30 and for the 
mild AD group between 18 and 30. The mean MMSE scores of the two patient groups 
indicate a very mildly impaired general cognitive status of the MCI patients and a 
mildly impaired general cognitive status of the AD patients. There was a trend towards 
higher MMSE scores in the MCI patients, t(34) = 1.73, p = .092.  
Retrospective episodic memory of MCI and AD patients. 
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Table 1 displays the CERAD-NAB memory subtest scores as age-, gender-, and 
education-adjusted z-scores according to the norms provided by a large healthy elderly 
Swiss German sample, thus allowing for comparison between the test performances of 
the two patient groups and the test performances of demographically-matched healthy 
older adults. Compared to the healthy normative sample, as a group, the MCI patients 
showed only mild verbal retrospective memory impairments (mean CERAD-NAB 
word list subtests z-scores between one and two standard deviations and mean 
CERAD-NAB visual free delayed recall subtest z-score within one standard deviation 
below demographic-adjusted norms). In contrast, the mild AD patients showed severe 
verbal retrospective memory impairments (mean CERAD-NAB word list subtests z-
scores below at least two standard deviations below demographic-adjusted norms) and 
additionally a mild visual retrospective memory deficit (mean CERAD-NAB visual 
free delayed recall subtest z-score between one and two standard deviations below 
demographic-adjusted norms). The MCI patients performed significantly better than the 
mild AD patients on all CERAD-NAB memory subtests (word list learning: t(27.77) = 
2.65, p = .013; word list delayed free recall: t(32.41) = 4.83, p < .001; word list delayed 
recognition: t(34) = 2.54, p = .016; visual delayed recall: t(24.80) = 2.62, p = .015). 
Group Differences in Prospective and Retrospective Memory Complaints 
In Table 2, the mean PRMQ Prospective and the mean Retrospective Scale 
scores for each of the three participant groups and the whole sample are presented. 
Additionally, in the last column of Table 2 the means for the average between the 
Prospective and Retrospective Scale scores for each participant group and the whole 
sample are provided. 
------------------------------- 
Insert Table 2 about here 
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------------------------------- 
A 3x2-mixed ANOVA with participant group as between-subject factor and 
type of memory complaint (i.e., Prospective versus Retrospective Scale of the PRMQ) 
as within-subjects factor was conducted to assess whether the participant groups 
differed in the amount of prospective versus retrospective memory complaints. The 
main effect of group was not significant (F(2, 103) = 0.03, p < .97, partial η2 = 0.001), 
indicating that the groups did not differ in the amount of reported memory failures 
(regardless of which type). As can be seen in the last column of Table 2, the means for 
of the average between the Prospective and Retrospective Scale scores were very 
similar for all groups. There was a main effect of type of memory complaint (F(1, 103) 
= 4.16, p = .044, partial η2 = 0.039). As can be seen in the last row of Table 2, the mean 
Prospective Scale scores of the whole sample were lower than the mean Retrospective 
Scale scores of the whole sample. This indicates that in the whole sample more 
retrospective than prospective memory failures were reported. Furthermore, there was 
an interaction between participant group and type of memory complaint (F(2, 103) = 
4.33, p = .016, partial η2 = 0.077). As can be deducted from Table 2, the Prospective 
and Retrospective Scale scores of the healthy older adults and the MCI patients were 
very similar, whereas the Retrospective Scale scores of the AD patients were greater 
than their Prospective Scale scores. Post-hoc paired t tests confirmed that there was no 
difference between the Prospective and Retrospective Scale scores of the healthy older 
adults (t(69) = -.55, p < .60, d = 0.04) and of the MCI patients (t(26) = -.35, p < .80, d = 
0.05), whereas this difference was marginally significant for the AD patients, t(8) = 
2.22, p = .057, d = -0.56. Therefore, the main effect of greater Retrospective than 
Prospective Scale scores was probably mainly caused by the greater Retrospective than 
Prospective Scale scores of the AD patients. In conclusion, these analyses indicate that 
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the participant groups did not differ in their mean level of prospective and retrospective 
memory complaints. However, the AD patients reported more retrospective than 
prospective memory complaints, whereas the healthy older participants and the MCI 
patients complained as much about prospective as about retrospective memory failures.  
Relation of Prospective and Retrospective Memory Complaints to Executive 
Functioning in Healthy Older Adults and MCI Patients 
To assess whether prospective memory complaints were differentially 
associated with executive functioning for both healthy older adults and MCI patients, 
Pearson product-moment correlations between the PRMQ Prospective and 
Retrospective Scale scores and the three applied executive functions tests scores (i.e., 
Digit Span backward scores as working memory measure, TMT-B/A scores as task 
switching measure, and third plateVictoria-Stroop Test scores as inhibition measure) 
were calculated separately for the healthy older adults and the MCI patients. The results 
of these analyses are displayed in Table 3. 
------------------------------- 
Insert Table 3 about here 
------------------------------- 
Healthy older adults. 
The PRMQ Prospective Scale scores correlated significantly only with the 
Victoria-Stroop Test scores. Additionally, there was a marginally significant correlation 
between the PRMQ Retrospective Scale scores and the TMT-B/A scores. Both 
correlations were positive and of moderate size. This indicates a) that healthy older 
adults who rated their prospective memory competence as poor tended to have a poor 
inhibition performance and b) that healthy older adults who rated their retrospective 
memory competence as poor tended to have a poor task switching performance. 
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MCI patients. 
The PRMQ Prospective Scale scores did not significantly correlate with any of 
the included executive functions tests. In contrast, the PRMQ Retrospective Scale 
scores correlated significantly with the TMT B/A scores. This correlation was positive 
and of moderate size, indicating that MCI patients who rated their retrospective 
memory competence as poor tended to have a poor task switching performance. 
Discussion 
The aims of this study were to evaluate (a) the usefulness of subjective 
prospective in comparison to subjective retrospective memory complaints for an initial 
screening for MCI and (b) the appropriateness of the proposal that awareness of 
everyday prospective, but not retrospective memory failures, is related to executive 
functioning in healthy older adults and patients with MCI. For this purpose, 71 healthy 
older adults, 27 individuals with a clinical diagnosis of MCI, and 9 individuals with a 
clinical diagnosis of mild AD were asked to complete the Prospective and 
Retrospective Memory Questionnaire (PRMQ). Their scores on the Prospective Scale 
of the PRMQ were used as a measure for subjective prospective memory complaints 
and their scores on the Retrospective Scale of the PRMQ as a measure of subjective 
retrospective memory complaints. In addition, the participants completed three 
executive functions tests. 
Since previous findings indicate that – on the one hand – prospective memory is 
an equally sensitive marker as retrospective memory for preclinical and mild AD and – 
on the other hand – awareness of everyday prospective memory deficits is greater than 
awareness of everyday retrospective memory deficits, it was anticipated that all 
participant groups complain more about prospective than retrospective memory 
failures. Additionally, it was expected that the MCI patients report more prospective 
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and retrospective memory failures than the healthy older adults. The AD patients were 
expected to report more prospective memory failures than the MCI patients. However, 
due to their well-known diminished insight in this cognitive ability, we predicted that 
the AD patients report a similar amount of retrospective memory failures as the MCI 
patients. Interestingly, contrary to these predictions, we found that both the healthy 
older adults and the MCI patients complained as much about prospective as about 
retrospective memory deficits, while the mild AD patients even complained more about 
retrospective than prospective memory problems. Additionally, neither the amount of 
subjective prospective nor retrospective memory complaints could discriminate the 
MCI patients from the healthy older adults or the AD patients. However, the difference 
between subjective prospective and retrospective memory complaints distinguished the 
patients with mild AD from the other two participant groups, thus suggesting the 
usefulness of assessing both subjective prospective and retrospective memory 
complaints for a screening for mild AD. 
To evaluate whether awareness of everyday prospective memory failures is 
specifically related to executive functioning in healthy older adults as well as in MCI 
patients, correlations between their scores on the Prospective and Retrospective Scale 
of the PRMQ and on the three executive functions tests were calculated separately for 
the two participant groups. It was expected that for both healthy older adults and MCI 
patients, their scores on the Prospective Scale, but not on the Retrospective Scale of the 
PRMQ, were related to their scores on at least one of the executive functions tests. 
Although the scores of our healthy older adults on the Prospective Scale were 
correlated with their scores on one of the three executive functions tests, in contrast to 
the predictions the scores of the MCI patients on the Prospective Scale were not 
correlated to any of the included executive functions tests. Furthermore, for both the 
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healthy older adults and the MCI patients, the Retrospective Scale scores were 
correlated with one of the executive functions tests. Nevertheless, a differential pattern 
of associations emerged: the Prospective Scale scores of the healthy older adults were 
correlated to their scores on the inhibition test, while the Retrospective Scale scores of 
both the healthy older adults and the MCI patients were correlated to their scores on the 
task switching test. 
With regard to previous empirical evidence, our finding of a similar amount of 
subjective prospective and retrospective memory complaints in a group of healthy older 
adults is surprising. To recap, all previous studies using the PRMQ (Crawford et al., 
2003; Kliegel & Jäger; 2006; Mäntylä, 2003; Rönnlund et al., 2008; Singer et al., 2006; 
Smith et al., 2000) reported a higher amount of subjective prospective than 
retrospective memory complaints in healthy samples. A comparison of our data with 
that of Kliegel and Jäger (2006) who applied the same PRMQ version in another Swiss 
healthy sample indicates a particularly high amount of subjective retrospective memory 
complaints in our sample (PRMQ Retrospective Scale: M = 18.87, SD = 4.98 vs. 
Kliegel et al.: M = 16.48, SD = 3.84), whereas the amount of subjective prospective 
complaints was very similar in both samples (PRMQ Prospective Scale: M = 19.06, SD 
= 4.38 vs. Kliegel et al.: M = 18.16, SD = 4.20). With respect to possible variables 
moderating this effect, one factor may be age. Our sample of healthy adults was older 
(M = 73.20, SD = 7.34, 54-91 years) than Kliegel and Jäger’s sample (M = 44.11, SD = 
18.94) and the samples of the other previous studies on the PRMQ (Crawford et al., 
2003: M = 63.62, SD = 15.59, 17-94 years ; Mäntylä, 2003: age range 35-55 years; 
Rönnlund et al., 2008: M = 60.58, SD = 16.42, 35-90 years; Singer et al., 2006: M = 51, 
19-85 years; Smith et al., 2000: M = 58.47, 17-93 years1). Thus, our finding of a similar 
amount of subjective prospective and retrospective memory complaints in the healthy 
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older adults might be caused by a specific increase of subjective retrospective memory 
complaints beginning in old age, while the amount of subjective prospective memory 
complaints may stay rather stable across the lifespan. 
In line with this proposal, we found a significant positive correlation between 
PRMQ Retrospective Scale scores and age (r = .26, p = .030) for the healthy older 
adults, whereas the PRMQ Prospective Scale scores and age were not significantly 
correlated to each other. In contrast, in previous studies on the PRMQ with altogether 
younger samples consistently no significant correlations between PRMQ Retrospective 
Scale scores and age were found, whereas the findings regarding the correlation 
between PRMQ Prospective Scale scores and age were very diverse: ranging from a 
weak negative correlation (r = -.21; Rönnlund et al., 2008) to no correlation (Crawford 
et al., 2003) to a weak positive correlation (r = .13; Singer et al., 2006). 
The specific increase of subjective retrospective memory complaints in old age 
might be related to the onset of retrospective memory decline around the age of 60 
years (e.g., Rönnlund, Nyberg, Bäckman, & Nilsson, 2005; Schaie, 2005) or to a 
greater direction of attention to retrospective memory failures from this age on due to 
the generally expected onset of retrospective memory decline at this age in Western 
cultures (Heckhausen, Dixon, & Baltes, 1989). On development of prospective memory 
over the lifespan no longitudinal data is yet available. Cross-sectional studies 
comparing two extreme age groups (adults aged between 18-30 years and adults aged 
above 60 years) generally found performance decrements for older adults in laboratory 
prospective memory tasks, whereas they typically outperformed younger adults in 
naturalistic prospective memory tasks (for meta-analyses see Henry, MacLeod, 
Philipps, & Crawford, 2004; Uttl, 2008). Since the latter tasks are more similar to 
everyday prospective memory tasks targeted by PRMQ items, it seems reasonable to 
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assume that subjective prospective memory complaints do not increase in old age. 
Furthermore, the more negative functional and social consequences of prospective as 
compared to retrospective memory failures may lead to a close monitoring of 
prospective memory performance from early adulthood on and to an early development 
and long practise of strategies in order to keep it on a similar level over the lifespan. 
Accordingly, the reliance on external aids, such as calendars, notebooks, reminder 
notes, or to-do-lists, for managing everyday prospective memory tasks is a common 
practice in the normal population from early adulthood on (Long, Cameron, Harju, 
Lutz, & Means, 1999), whereas such external aids seem to be rarely employed for 
everyday retrospective memory tasks such as remembering names, object locations, or 
conversations. 
One possible reason why both subjective prospective and retrospective memory 
complaints did not discriminate the MCI patients from the healthy older adults in our 
study may be that they were relatively mildly impaired in retrospective memory 
compared to the MCI patient groups in previous studies (Clément et al., 2008; De Jager 
& Budge, 2005; Perrotin et al., 2007) demonstrating that MCI patients report a higher 
level of subjective memory complaints than healthy older adults. In these studies, test 
performance of at least 1.5 standard deviations below age-adjusted norms was used to 
define memory impairment, whereas we used a cut-off score of one standard deviation 
only and the mean scores of our MCI patients in the CERAD-NAB retrospective 
memory subtests were all above 1.5 standard deviations below age-adjusted norms. It 
might be possible that because of their mild impairment and an appropriate use of 
external aids, our MCI patients were still able to manage everyday retrospective and 
prospective memory tasks as well as healthy older adults. Moreover, the MCI patients 
may not have complained more about prospective than retrospective memory deficits 
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because they still put more effort into managing prospective memory tasks and were, 
due to their greater practise in using external aids for this type of everyday memory 
task, more successful in accomplishing them. Findings by Marsh, Hicks, and Landau 
(1998) indicate that mild retrospective memory deficits can be in fact compensated by 
the use of daily planners. They reported that young healthy adults that habitually used 
daily planners for managing their everyday prospective memory tasks had worse 
retrospective memory abilities than young healthy adults who did not use daily 
planners, but were able to complete a similar amount of prospective memory tasks 
during one week. Furthermore, recently improvements in the functional ability of MCI 
patients after a short training in the use of an electronic calendar system have been 
demonstrated (Greenaway, Hanna, Lepore, & Smith, 2008), showing that MCI patients, 
despite their mild cognitive impairments, are able to successfully apply external 
memory aids. 
In contrast to the MCI patients, the mild AD patients in this study were severely 
impaired in retrospective memory tasks and had also other cognitive deficits. This may 
have hindered them in the appropriate use of external memory aids. Therefore, the 
finding that they reported a similar level of prospective and retrospective memory 
failures as the healthy older adults and the MCI patients seems to be most likely caused 
by a diminished insight in the severity of their prospective and retrospective memory 
impairment. However, since they reported more retrospective than prospective memory 
impairments, their insight in their retrospective memory competence seems to be more 
preserved than their insight in their prospective memory impairments. On the other 
hand, Smith et al. (2000) reported that carers of AD patients are more frustrated about 
the patients’ prospective than retrospective memory failures. Therefore, they may 
relieve the AD patients from many everyday prospective memory tasks. Consequently, 
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the AD patients may indeed experience fewer everyday prospective than retrospective 
memory failures. Alternatively, it might be easier for the AD patients and their carers to 
identify and accept retrospective memory failures since their physicians presented them 
as the core symptom of the disease, whereas they did not mention prospective memory 
failures because of their little familiarity with this type of episodic memory. 
In our study, we could not confirm Mäntylä’s (2003) proposal of a differential 
relation of subjective prospective memory complaints to executive functioning, since 
only for the healthy older adults the PRMQ Prospective Scale scores were correlated 
with an executive functions test, while the PRMQ Retrospective Scale scores were 
correlated to an executive functions test for both the healthy older adults and the MCI 
patients. This might be caused by the fact that the Retrospective Scale included a 
similar amount of questions relating to tasks demanding self-initiated retrieval as the 
Prospective Scale. In line with this suggestion, Dubreuil, Adam, Bier, and Gagnon 
(2007) could not find a significant correlation between subjective mainly retrospective 
memory complaints with a classical retrospective memory task. However, when they 
separated controlled and automatic memory processes in this task with the Process 
Dissociation Procedure, they could demonstrate a significant correlation between the 
subjective memory complaints and the controlled processes. Subjective prospective 
memory complaints may be rather related to planning instead of working memory, 
inhibition, or task switching that were measured with the executive functions tests 
included in this study. In everyday life, people may indeed try to schedule their 
intended activities so that interruptions of or switches between activities are avoided 
and, therefore, their timely execution does not depend critically on inhibition or task 
switching abilities. 
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A clear limitation of this study is the small sample size of the mild AD patients, 
thus diminishing the power of the statistical analyses and particularly challenging non-
significant findings. However, for the main effect of group on subjective prospective 
and retrospective memory complaints as well as for the difference between these two 
types of memory complaints in the healthy older adults and in the MCI patients the 
observed effect sizes were very small, whereas a medium effect size was found for the 
difference in the mild AD patients, indicating a replication of our findings with larger 
samples would be worthwhile. Another limitation of this study is the use of 
convenience samples. The MCI and mild AD patients were recruited from a 
gerontopsychiatric hospital and thus may have been more aware of their memory 
problems than similarly affected individuals that do not seek medical advice. The 
healthy older adults were community dwelling volunteers. They may have a better 
memory and thus may complain less about memory failures than the general older 
population. Consequently, the distribution of the PRMQ to a population-based sample 
of older adults would be desirable in the future. Furthermore, individuals with MCI 
constitute a heterogeneous group with regard to cognitive profile and conversion to 
AD. At the present, a lot of research is dedicated to determining the predictive power 
for AD of different cognitive subtypes of MCI (Petersen & Negash, 2008). In future 
research, it would be useful to include a cognitively more homogeneous sample of 
patients with a subtype of MCI that has high predictive power for AD. Moreover, we 
have explained our findings with differences between healthy younger and older adults, 
MCI patients, and AD patients in prospective and retrospective memory ability, 
awareness for failures of, the use of external aids for, or everyday demands on 
prospective and retrospective memory, but did not record most of these variables or if 
so not in all groups. To test the validity of our explanations, in a follow-up study the 
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inclusion of an additional sample of healthy young or middle-aged adults and the 
measurement of the aforementioned variables in all included groups would be 
desirable. Furthermore, it would be interesting to directly target insight in prospective 
and retrospective memory in MCI patients and mild AD patients by comparing their 
own ratings on the PRMQ with that of their caregivers. For this purpose, the proxy-
rating version of the PRMQ (Crawford, Henry, Ward, & Blake, 2006) could be applied. 
In conclusion, our results indicate that the assessment of subjective prospective 
and retrospective memory complaints with the Prospective and Retrospective Scales of 
the PRMQ is particularly useful for the discrimination of mild AD patients from 
healthy older adults and MCI patients. However, the mild AD patients could not be 
distinguished from the other groups by a greater amount of prospective or retrospective 
memory complaints but by a greater amount of retrospective relative to prospective 
memory complaints. Furthermore, our data point to a change of the relation between 
subjective prospective and retrospective memory complaints in healthy old age with a 
relative increase in retrospective memory complaints. However, for a deeper 
understanding of self-reports on prospective and retrospective memory competence in 
normal adults, MCI patients, and AD patients more research on variables influencing 
them is needed.  
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Footnotes 
1All available data reported. 
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Table 1 
Participant Groups Characteristics  
 
Control 
(n = 71) 
M (SD) 
MCI 
(n = 27) 
M (SD) 
AD 
(n = 9) 
M (SD) 
Age (years) 73.20 (7.34) 73.44 (6.84) 75.33 (6.56) 
Proportion of women 59.2 %  70.4 % 88.9 % 
Years of schooling 13.30 (2.86) 12.15 (3.27) 11.11 (1.54) 
Intelligence (IQ)a 124.0 (52) 107.0 (50)b 104.0 (15) 
GDS scores  2.02 (1.54) 2.22 (1.39) 
Proportion of outpatients  88.9 % 77.8 % 
MMSE  27.44 (2.08) 25.78 (3.53) 
Word list learningc  -1.34 (1.69) -2.48 (0.86) 
Word list delayed free recallc  -1.08 (1.48) -2.76 (0.60) 
Word list delayed recognitionc  -1.26 (2.60) -3.84 (2.76) 
Visual delayed free recallc  -0.79 (1.50) -1.87 (0.86) 
Note. aMedians and ranges are reported because group variances were inhomogeneous. 
b
n = 25. cCERAD-NAB subtests. In age-, gender-, and education-adjusted z-scores. 
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Table 2 
Comparison of the Participants Groups for the PRMQ Prospective (PS) and 
Retrospective Scale (RS) Scores 
Group n 
PS 
M (SD) 
RS 
M (SD) 
Average between PS 
and RS 
M (SD) 
Control 70 19.06 (4.38) 18.87 (4.24) 18.96 (4.41) 
MCI 27 18.85 (5.82) 18.56 (4.82) 18.70 (4.41) 
AD 9 17.22 (6.08) 20.56 (5.90) 18.89 (4.41) 
Whole sample 106 18.93 (4.52) 18.85 (4.91) 18.85 (6.10) 
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Table 3 
Correlations between the PRMQ Prospective (PS) and Retrospective Scale Scores (RS) 
and Executive Functions Tests for Healthy Older Adults and MCI Patients 
 Controls MCI 
 PS RS PS RS 
Digit Span backward -.03 (70) -.15 (69) -.03 (25) -.18 (25) 
TMT-B/A .16 (71) .23 (70)† .18 (20) .60 (20)** 
3rd plate Stroop .24 (70)* .15 (69) .26 (25) .10 (25) 
Note. Pearson product-moment correlations are presented with n in brackets.  
†p = .058. *p < .05. **p < .01. 
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Figure Captions 
Figure 1. Selection procedure for the MCI and the mild AD patients. 
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311 patients with neuropsychological examination 
for self- or informant- reported cognitive decline 
210 unable or 
disagreed to 
complete 
PRMQ 
98 one SD below 
age-adjusted norms  
Neuropsychological 
test performance 
3 greater than one 
SD below age-
adjusted norms  
1 withdrew Whole diagnostic 
assessment 
34 neurological 
diseases 
17 psychiatric 
disorders 
10 alcohol abuse 
Other neurological, 
systemic, or 
psychiatric illnesses, 
or substance abuse 
Final diagnosis 
(everyday 
functioning + 
cognitive profile) 
 
9 mild AD 
(impaired everyday 
functioning + 
typical cognitive 
profile) 
 
36 no evidence  
27 MCI 
(mostly preserved 
everyday functioning 
+ mild cognitive 
deficits) 
101 completed  
97 completed  
